Home Featured Page 163

Featured

Latest

Pα+ Psychedelic Bulletin #215: FDA’s Move to Single-Trial Approvals; Freedom to Heal Act Looks to Unlock Right to Try Psychedelics; Compass Clarifies Q1 Readout...

The View from D.C.: Psychedelic Politics, Blockers and Approvals on the Horizon

Logan Davidson – American Ibogaine, State Strategy, and the Future of Psychedelic Policy

Areyto Boriken – Ethnobotanical Adventure

The Ram Dass Institute of Psychedelic Studies with The Dying Inaugural Event on Maui

atai Life Sciences Company Kures Therapeutics Appoints Dr. Chad Beyer as...

Algernon Pharmaceuticals Announces Pricing of Public Offering of Units

Tryp Therapeutics Strengthens IP Portfolio with Provisional Patent Application for Binge...

Mindset Pharma Announces Development of Novel, Optimized, Intranasal Formulation

Optimi Health Initiates Agreement With SABI Mind For Therapeutic Supplies Of...

HAVN Life Enters Supply Agreement with MPB Group Inc.

PsyBio Therapeutics to Seek Approval of Proposed Share Consolidation at Annual...

Numinus Unveils New Logo and Brand Identity

Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking...

Digging Up Druggable Targets: Psilocybin Efficacy in a Model of OCD

1...162163164...303 Page 163 of 303

Pα+ Psychedelic Bulletin #215: FDA’s Move to Single-Trial Approvals; Freedom to...

The View from D.C.: Psychedelic Politics, Blockers and Approvals on the...

Logan Davidson – American Ibogaine, State Strategy, and the Future of...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.